ADMA Investor Alert: ADMA Biologics Investors Notified of the Important August 10 Deadline in Filed Securities Fraud Class Action Lawsuit
A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating f
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.